生物谷连亏四年，原实控人侵犯公司利益获刑

Core Viewpoint - The company reported a revenue decline of 16.12% in 2025, with a net profit loss of 55.84 million yuan, although it reduced its loss by 24.94% compared to the previous year [1] Financial Performance - In 2025, the company achieved a revenue of 433 million yuan, down from the previous year [1] - The net profit attributable to shareholders was -55.84 million yuan, indicating a reduction in losses compared to the previous year [1] - The company has experienced consecutive losses for four years, with net profits of -48.91 million yuan in 2022, -12.20 million yuan in 2023, -74.40 million yuan in 2024, and -55.84 million yuan in 2025 [2] Legal Issues - The former actual controller of the company was sentenced for damaging the company's interests, involving illegal financial activities that misappropriated company funds for personal use [3][4] - The court sentenced the former chairman to three years in prison and imposed a fine of 5 million yuan, while the former financial director received a sentence of one year and six months with a fine of 200,000 yuan [4] - The company received 62 million yuan in execution funds from the court as a result of the legal proceedings [5] Market Performance - As of the close on February 12, the company's stock price fell by 1.92%, trading at 9.18 yuan per share, with a total market capitalization of 1.138 billion yuan [6]